Literature DB >> 34302614

Potential of electron transfer and its application in dictating routes of biochemical processes associated with metabolic reprogramming.

Ronghui Yang1,2, Guoguang Ying3,4,5, Binghui Li6,7,8.   

Abstract

Metabolic reprogramming, such as abnormal utilization of glucose, addiction to glutamine, and increased de-novo lipid synthesis, extensively occurs in proliferating cancer cells, but the underneath rationale has remained to be elucidated. Based on the concept of the degree of reduction of a compound, we have recently proposed a calculation termed as potential of electron transfer (PET), which is used to characterize the degree of electron redistribution coupled with metabolic transformations. When this calculation is combined with the assumed model of electron balance in a cellular context, the enforced selective reprogramming could be predicted by examining the net changes of the PET values associated with the biochemical pathways in anaerobic metabolism. Some interesting properties of PET in cancer cells were also discussed, and the model was extended to uncover the chemical nature underlying aerobic glycolysis that essentially results from energy requirement and electron balance. Enabling electron transfer could drive metabolic reprogramming in cancer metabolism. Therefore, the concept and model established on electron transfer could guide the treatment strategies of tumors and future studies on cellular metabolism.
© 2021. Higher Education Press.

Entities:  

Keywords:  aerobic glycolysis; cancer metabolism; cell proliferation; metabolic reprogramming; potential of electron transfer

Year:  2021        PMID: 34302614     DOI: 10.1007/s11684-021-0866-1

Source DB:  PubMed          Journal:  Front Med        ISSN: 2095-0217            Impact factor:   4.592


  63 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

2.  Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation.

Authors:  Mohit Jain; Roland Nilsson; Sonia Sharma; Nikhil Madhusudhan; Toshimori Kitami; Amanda L Souza; Ran Kafri; Marc W Kirschner; Clary B Clish; Vamsi K Mootha
Journal:  Science       Date:  2012-05-25       Impact factor: 47.728

3.  Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction.

Authors:  David R Wise; Ralph J DeBerardinis; Anthony Mancuso; Nabil Sayed; Xiao-Yong Zhang; Harla K Pfeiffer; Ilana Nissim; Evgueni Daikhin; Marc Yudkoff; Steven B McMahon; Craig B Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-24       Impact factor: 11.205

Review 4.  Glutamine addiction: a new therapeutic target in cancer.

Authors:  David R Wise; Craig B Thompson
Journal:  Trends Biochem Sci       Date:  2010-08       Impact factor: 13.807

5.  BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1.

Authors:  Martje Tönjes; Sebastian Barbus; Yoon Jung Park; Wei Wang; Magdalena Schlotter; Anders M Lindroth; Sabrina V Pleier; Alfa H C Bai; Daniela Karra; Rosario M Piro; Jörg Felsberg; Adele Addington; Dieter Lemke; Irene Weibrecht; Volker Hovestadt; Claudio G Rolli; Benito Campos; Sevin Turcan; Dominik Sturm; Hendrik Witt; Timothy A Chan; Christel Herold-Mende; Ralf Kemkemer; Rainer König; Kathrin Schmidt; William-Edmund Hull; Stefan M Pfister; Manfred Jugold; Susan M Hutson; Christoph Plass; Jürgen G Okun; Guido Reifenberger; Peter Lichter; Bernhard Radlwimmer
Journal:  Nat Med       Date:  2013-06-23       Impact factor: 53.440

6.  Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes.

Authors:  J S Flier; M M Mueckler; P Usher; H F Lodish
Journal:  Science       Date:  1987-03-20       Impact factor: 47.728

Review 7.  Metabolic regulation of cell growth and proliferation.

Authors:  Jiajun Zhu; Craig B Thompson
Journal:  Nat Rev Mol Cell Biol       Date:  2019-07       Impact factor: 94.444

8.  Elevation of circulating branched-chain amino acids is an early event in human pancreatic adenocarcinoma development.

Authors:  Jared R Mayers; Chen Wu; Clary B Clish; Peter Kraft; Margaret E Torrence; Brian P Fiske; Chen Yuan; Ying Bao; Mary K Townsend; Shelley S Tworoger; Shawn M Davidson; Thales Papagiannakopoulos; Annan Yang; Talya L Dayton; Shuji Ogino; Meir J Stampfer; Edward L Giovannucci; Zhi Rong Qian; Douglas A Rubinson; Jing Ma; Howard D Sesso; John Michael Gaziano; Barbara B Cochrane; Simin Liu; Jean Wactawski-Wende; JoAnn E Manson; Michael N Pollak; Alec C Kimmelman; Amanda Souza; Kerry Pierce; Thomas J Wang; Robert E Gerszten; Charles S Fuchs; Matthew G Vander Heiden; Brian M Wolpin
Journal:  Nat Med       Date:  2014-09-28       Impact factor: 53.440

9.  Spatially resolved metabolomics to discover tumor-associated metabolic alterations.

Authors:  Chenglong Sun; Tiegang Li; Xiaowei Song; Luojiao Huang; Qingce Zang; Jing Xu; Nan Bi; Guanggen Jiao; Yanzeng Hao; Yanhua Chen; Ruiping Zhang; Zhigang Luo; Xin Li; Luhua Wang; Zhonghua Wang; Yongmei Song; Jiuming He; Zeper Abliz
Journal:  Proc Natl Acad Sci U S A       Date:  2018-12-17       Impact factor: 11.205

10.  Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion.

Authors:  Cristovão M Sousa; Douglas E Biancur; Xiaoxu Wang; Christopher J Halbrook; Mara H Sherman; Li Zhang; Daniel Kremer; Rosa F Hwang; Agnes K Witkiewicz; Haoqiang Ying; John M Asara; Ronald M Evans; Lewis C Cantley; Costas A Lyssiotis; Alec C Kimmelman
Journal:  Nature       Date:  2016-08-10       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.